RESEARCH ARTICLE


The Imaging Probe Development Center and the Production of Molecular Imaging Probes



Gary L Griffiths*
Director, Imaging Probe Development Center, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 479
Abstract HTML Views: 410
PDF Downloads: 163
Total Views/Downloads: 1052
Unique Statistics:

Full-Text HTML Views: 279
Abstract HTML Views: 217
PDF Downloads: 92
Total Views/Downloads: 588



© Gary L. Griffiths; Licensee Bentham Open.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.

* Address correspondence to this author at the Director, Imaging Probe Development Center, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA; E-mail griffithsgl@nhlbi.nih.gov


Abstract

The Imaging Probe Development Center (IPDC), part of the NIH Roadmap for Medical Research Initiative (http://nihroadmap.nih.gov/) recently became fully operational at its newly refurbished laboratories in Rockville, MD. The IPDC (http://nihroadmap.nih.gov/molecularlibraries/ipdc/) is dedicated to the production of known and novel molecular imaging probes, with its services currently being used by the NIH intramural community, although in the future it is intended that the extramural community will also benefit from the IPDC’s resources. The Center has been set up with the belief that molecular imaging, and the probe chemistry that underpins it, will constitute key technologies going forward. As part of the larger molecular libraries and imaging initiative, it is planned that the IPDC will work closely with scientists from the molecular libraries effort. Probes produced at the IPDC include optical, radionuclide and magnetic resonance agents and may encompass any type of contrast agent. As IPDC is a trans-NIH resource it can serve each of the 27 Institutes and Centers that comprise NIH so its influence can be expected to impact widely different subjects and disease conditions spanning biological research. IPDC is expected to play a key part in interdisciplinary collaborative imaging projects and to support translational R&D from basic research through clinical development, for all of the imaging modalities. Examples of probes already prepared or under preparation are outlined to illustrate the breadth of the chemistries undertaken together with a reference outline of the diverse biological applications for which the various probes are intended.